Vitro. de Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vitro. de.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Packaging earnings growth	18.9%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

Vitro, S.A.B. de C.V. (BMV:VITROA) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Mar 13

Not Many Are Piling Into Vitro, S.A.B. de C.V. (BMV:VITROA) Stock Yet As It Plummets 48%

Jan 24

Vitro. de's (BMV:VITROA) Returns On Capital Not Reflecting Well On The Business

Jan 03

What Is The Ownership Structure Like For Vitro, S.A.B. de C.V. (BMV:VITROA)?

Jan 11

How Much Did Vitro. de's(BMV:VITROA) Shareholders Earn From Share Price Movements Over The Last Three Years?

Dec 21

Are Vitro. de's (BMV:VITROA) Statutory Earnings A Good Guide To Its Underlying Profitability?

Nov 18

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vitro. de has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BMV:VITRO A - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	292	-43	167	185	N/A
6/30/2024	301	-10	N/A	N/A	N/A
3/31/2024	306	88	N/A	N/A	N/A
12/31/2023	311	123	255	273	N/A
9/30/2023	-1,273	125	379	298	N/A
6/30/2023	2,443	63	80	279	N/A
3/31/2023	2,402	35	129	316	N/A
12/31/2022	252	33	266	275	N/A
9/30/2022	2,268	-81	43	171	N/A
6/30/2022	2,136	-71	10	127	N/A
3/31/2022	2,036	-87	-104	5	N/A
12/31/2021	1,958	-107	-126	-25	N/A
9/30/2021	1,939	-145	-75	36	N/A
6/30/2021	1,924	-126	-7	97	N/A
3/31/2021	1,742	-178	-1	95	N/A
12/31/2020	1,768	-45	119	224	N/A
9/30/2020	1,780	49	176	298	N/A
6/30/2020	1,858	76	156	297	N/A
3/31/2020	2,125	174	166	324	N/A
12/31/2019	2,180	64	122	289	N/A
9/30/2019	2,216	130	53	172	N/A
6/30/2019	2,235	148	19	145	N/A
3/31/2019	2,236	119	27	201	N/A
12/31/2018	2,238	162	62	222	N/A
9/30/2018	2,225	176	66	275	N/A
6/30/2018	2,208	178	N/A	318	N/A
3/31/2018	2,202	214	N/A	317	N/A
12/31/2017	2,075	194	N/A	294	N/A
9/30/2017	1,958	208	N/A	327	N/A
6/30/2017	1,634	204	N/A	315	N/A
3/31/2017	1,266	199	N/A	299	N/A
12/31/2016	957	175	N/A	269	N/A
9/30/2016	837	145	N/A	265	N/A
6/30/2016	865	34	N/A	257	N/A
3/31/2016	884	-10	N/A	297	N/A
12/31/2015	820	-70	N/A	296	N/A
9/30/2015	763	-133	N/A	246	N/A
6/30/2015	754	-95	N/A	255	N/A
3/31/2015	745	-93	N/A	248	N/A
12/31/2014	755	-87	N/A	257	N/A
9/30/2014	1,015	-50	N/A	253	N/A
6/30/2014	1,269	11	N/A	294	N/A
3/31/2014	1,468	-18	N/A	314	N/A
12/31/2013	1,646	44	N/A	306	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VITRO A's forecast earnings growth is above the savings rate (8.1%).

Earnings vs Market: Insufficient data to determine if VITRO A's earnings are forecast to grow faster than the MX market

High Growth Earnings: Insufficient data to determine if VITRO A's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if VITRO A's revenue is forecast to grow faster than the MX market.

High Growth Revenue: Insufficient data to determine if VITRO A's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VITRO A's Return on Equity is forecast to be high in 3 years time

Vitro. de Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target increased to Mex$80.00

Price target increased to Mex$65.00

Recent updates

Third quarter 2024 earnings released

New minor risk - Share price stability

Second quarter 2024 earnings released

First quarter 2024 earnings released: EPS: US$0.053 (vs US$0.08 in 1Q 2023)

New minor risk - Financial position

Vitro, S.A.B. de C.V. (BMV:VITROA) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Full year 2023 earnings released: EPS: US$0.04 (vs US$0.038 in FY 2022)

Not Many Are Piling Into Vitro, S.A.B. de C.V. (BMV:VITROA) Stock Yet As It Plummets 48%

Investor sentiment deteriorates as stock falls 27%

Vitro. de's (BMV:VITROA) Returns On Capital Not Reflecting Well On The Business

New major risk - Share price stability

Investor sentiment improves as stock rises 45%

Third quarter 2023 earnings released: EPS: US$0.03 (vs US$0.03 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$0.077 (vs US$0.02 in 2Q 2022)

Full year 2022 earnings released: EPS: US$0.038 (vs US$0.23 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: US$0.034 loss per share (vs US$0.011 loss in 3Q 2021)

Second quarter 2022 earnings released: EPS: US$0.019 (vs US$0.02 loss in 2Q 2021)

First quarter 2022 earnings released: EPS: US$0.04 (vs US$0.001 loss in 1Q 2021)

Price target increased to Mex$80.00

Less than half of directors are independent

Full year 2021 earnings: Revenues in line with analyst expectations

Price target increased to Mex$65.00

Second quarter 2021 earnings released

Full year 2020 earnings released: US$0.096 loss per share (vs US$0.14 profit in FY 2019)

DHS Private Equity Trust (AXS) cancelled the acquisition of Vitro, S.A.B. de C.V. (BMV:VITRO A).

DHS Private Equity Trust (AXS) agreed to acquire Vitro, S.A.B. de C.V. (BMV:VITRO A) for approximately $1.2 billion.

What Is The Ownership Structure Like For Vitro, S.A.B. de C.V. (BMV:VITROA)?

How Much Did Vitro. de's(BMV:VITROA) Shareholders Earn From Share Price Movements Over The Last Three Years?

Market bids up stock over the past week

New 90-day high: Mex$25.37

Are Vitro. de's (BMV:VITROA) Statutory Earnings A Good Guide To Its Underlying Profitability?

New 90-day high: Mex$25.15

Third quarter earnings released

Solutia Inc. signed a definitive agreement to acquire the 51% stake it did not already own in Quimica M, S.A. de C.V. from Vitro SA de CV for approximately $20 million.

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies